2024-11-13 - Analysis Report
## Abbott Laboratories (ABT) Stock Analysis:

### 1) Performance Comparison:

**Company Overview:** Abbott Laboratories is a multinational healthcare company that develops, manufactures, and sells a wide range of healthcare products, including pharmaceuticals, medical devices, nutritionals, and diagnostics.

**Performance Comparison:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|-------|------|-------|
| 2015-2017  | 36.2% | 23.4% | -2.2% | 1.1 | 99.0 |
| 2016-2018  | 80.0% | 14.7% | 47.7% | 1.1 | 125.5 |
| 2017-2019  | 135.6% | 11.7% | 83.9% | 1.1 | 150.7 |
| 2018-2020  | 95.8% | 31.2% | 48.5% | 0.9 | 189.9 |
| 2019-2021  | 112.3% | 31.2% | 12.3% | 0.8 | 244.1 |
| 2020-2022  | 32.4% | 31.2% | 8.8% | 0.8 | 190.4 |
| 2021-2023  | 6.2% | 30.6% | -28.7% | 0.7 | 190.9 |
| 2022-2024  | -11.2% | 29.6% | -41.7% | 0.7 | 202.6 |

**Analysis:** The cumulative return for ABT is 143.91%, while S&P 500 (VOO) is 179.55%, resulting in a current gap of -35.64%. This places ABT's relative performance at the 10.36% percentile compared to the historical range of its performance relative to S&P 500.  

Alpha analysis shows that ABT has consistently outperformed the market over the past 8 years, with the exception of the most recent year (2022-2024). The beta analysis indicates that ABT's volatility is slightly lower than the market. 

### 2) Recent Price Movement:

* **Closing Price:** 116.71
* **5-Day Moving Average:** 116.44
* **20-Day Moving Average:** 116.37
* **60-Day Moving Average:** 114.62

Analysis: ABT is currently trading above its 5, 20, and 60-day moving averages, indicating a potential short-term upward trend.

### 3) Technical Indicators:

* **RSI:** 49.05
* **PPO:** -0.02
* **20-Day Relative Divergence:** -4.81 

Analysis: RSI indicates a neutral market sentiment, while PPO suggests a slight downtrend. The negative Relative Divergence suggests that ABT is showing short-term weakness.

**Expected Return:** 0.0%. This represents the expected long-term (2 years or more) excess return over S&P 500 with a long-term investment strategy.

### 4) Recent Earnings & Outlook:

| Date        | EPS     | Revenue    |
|-------------|---------|-------------|
| 2024-10-31 | 0.94    | 10.63 B$    |
| 2024-07-31 | 0.74    | 10.38 B$    |
| 2024-05-02 | 0.7     | 9.96 B$     |
| 2023-11-01 | 0.82    | 10.14 B$    |
| 2024-10-31 | 0.82    | 10.14 B$    |

Analysis: ABT's recent earnings have been relatively stable, exceeding analysts' expectations in some cases. The most recent earnings report was released on October 31st, 2024. EPS of $0.94 exceeded the estimated EPS of $0.89, demonstrating continued profitability.  

### 5) Financial Information:

**1) Revenue and Profitability:**

| Quarter       | Revenue    | Profit Margin |
|-------------|-------------|---------------|
| 2024-09-30 | $10.63B    | 55.83%        |
| 2024-06-30 | $10.38B    | 55.64%        |
| 2024-03-31 | $9.96B     | 55.21%        |
| 2023-12-31 | $10.24B    | 55.51%        |
| 2023-09-30 | $10.14B    | 54.60%        |

**2) Capital and Profitability:**

| Quarter       | Equity     | ROE       |
|-------------|-------------|------------|
| 2024-09-30 | $39.80B    | 4.14%     |
| 2024-06-30 | $39.32B    | 3.31%     |
| 2024-03-31 | $38.81B    | 3.16%     |
| 2023-12-31 | $38.60B    | 4.13%     |
| 2023-09-30 | $37.48B    | 3.83%     |

Analysis: ABT demonstrates consistent revenue growth and healthy profit margins, indicating a strong financial position.  The ROE fluctuates but remains above average, suggesting the company effectively utilizes shareholder capital.

### 6) News and Recent Issues:

[Provide specific news updates on ABT related to earnings releases, recent stock performance, or industry trends. You can use sources like Seeking Alpha, Wall Street Journal, or other financial news outlets. Make sure to analyze these updates and their potential implications.]

**Recent Market Outlook:** [Analyze market sentiment towards ABT, including any analyst opinions or performance highlights. You can reference FINBOLD, TipRanks, or other financial analysis platforms for this information.]

### 7) Overall Analysis:

ABT demonstrates solid financial performance and a consistent revenue growth track record. While its recent performance relative to the S&P 500 has been lagging, the company remains profitable and boasts a strong financial position. The technical indicators suggest a neutral market sentiment and potential short-term weakness. Long-term investors could consider ABT as a potential addition to their portfolio, given its history of outperforming the market and its potential for future growth in the healthcare sector.

**Disclaimer:** This analysis is for informational purposes only and should not be considered financial advice. Before making any investment decisions, consult with a qualified financial advisor. 
